Description What is Pinealon? Pinealon is a synthetic tripeptide — just three amino acids (Glu-Asp-Arg) — developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It belongs to a class of compounds called “bioregulators” — short peptides designed to target specific tissues and restore normal function. Pinealon specifically targets the central nervous system and pineal gland, making it a compound of interest for researchers studying brain health, neuroprotection, sleep, and cognitive aging. What Researchers Are Exploring Neuroprotection & Brain Health Research has explored Pinealon’s ability to protect brain cells from damage caused by oxidative stress, hypoxia (low oxygen), and other harmful conditions. Studies suggest it may support neuronal survival and reduce markers of brain cell damage. Cognitive Function Studies have examined whether Pinealon can support cognitive function — including learning, memory, and mental clarity — particularly in the context of age-related cognitive decline. Sleep & Circadian Rhythm Through its influence on the pineal gland, research has explored Pinealon’s effects on melatonin production and sleep quality — suggesting it may help restore more balanced circadian rhythm patterns. Aging & Neurodegeneration Pinealon has been studied in the context of age-related neurological decline, with research exploring whether bioregulator peptides can slow or reverse deterioration in brain tissue. Worth Noting Pinealon is part of Professor Khavinson’s broader programme of bioregulator peptide research — the same programme that produced Epitalon. While less well-known than some other peptides, it has a focused research profile relevant to anyone interested in brain health and neuroprotection. For research use only. Not intended for human consumption. Not approved by the FDA or TGA.
